Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Friche

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Cancer Research|May 15, 1992
Relationship of VP-16 to the classical multidrug resistance phenotypeM Sehested, E Friche, P B Jensen, et al.
British Journal of Cancer|February 1, 1993
Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cellsE Friche, E J Demant, M Sehested, et al.
Biochemical Pharmacology|January 15, 1991
Cytosolic free Ca2+ in daunorubicin and vincristine resistant Ehrlich ascites tumor cells. Drug accumulation is independent of intracellular Ca2+ changesP Bouchelouche, E Friche, M Sehested, et al.
Cancer Research|August 15, 1991
Decreased DNA topoisomerase II in daunorubicin-resistant Ehrlich ascites tumor cellsE Friche, M K Danks, C A Schmidt, et al.
Progress in Clinical and Biological Research|January 1, 1983
Mechanism of resistance to anthracyclines and vinca alkaloidsK Danø, T Skovsgaard, N I Nissen, et al.
Biochemical Pharmacology|June 17, 2000
Characterisation of multidrug-resistant Ehrlich ascites tumour cells selected in vivo for resistance to etoposideD Nielsen, C Maare, J Eriksen, et al.
Biochemical Pharmacology|June 1, 1990
In vitro circumvention of anthracycline--resistance in Ehrlich ascites tumour by anthracycline analoguesE Friche, P B Jensen, H Roed, et al.
Cancer Communications|January 1, 1990
The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumorE Friche, P B Jensen, M Sehested, et al.
British Journal of Cancer|July 1, 1990
Transport of the multidrug resistance modulators verapamil and azidopine in wild type and daunorubicin resistant Ehrlich ascites tumour cellsM Sehested, T Skovsgaard, P B Jensen, et al.
Biochemical Pharmacology|August 3, 1993
Antagonistic effect of the cardioprotector (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) on DNA breaks and cytotoxicity induced by the topoisomerase II directed drugs daunorubicin and etoposide (VP-16)M Sehested, P B Jensen, B S Sørensen, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Cancer Research|May 15, 1992
Relationship of VP-16 to the classical multidrug resistance phenotypeM Sehested, E Friche, P B Jensen, et al.
British Journal of Cancer|February 1, 1993
Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cellsE Friche, E J Demant, M Sehested, et al.
Biochemical Pharmacology|January 15, 1991
Cytosolic free Ca2+ in daunorubicin and vincristine resistant Ehrlich ascites tumor cells. Drug accumulation is independent of intracellular Ca2+ changesP Bouchelouche, E Friche, M Sehested, et al.
Cancer Research|August 15, 1991
Decreased DNA topoisomerase II in daunorubicin-resistant Ehrlich ascites tumor cellsE Friche, M K Danks, C A Schmidt, et al.
Progress in Clinical and Biological Research|January 1, 1983
Mechanism of resistance to anthracyclines and vinca alkaloidsK Danø, T Skovsgaard, N I Nissen, et al.
Biochemical Pharmacology|June 17, 2000
Characterisation of multidrug-resistant Ehrlich ascites tumour cells selected in vivo for resistance to etoposideD Nielsen, C Maare, J Eriksen, et al.
Biochemical Pharmacology|June 1, 1990
In vitro circumvention of anthracycline--resistance in Ehrlich ascites tumour by anthracycline analoguesE Friche, P B Jensen, H Roed, et al.
Cancer Communications|January 1, 1990
The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumorE Friche, P B Jensen, M Sehested, et al.
British Journal of Cancer|July 1, 1990
Transport of the multidrug resistance modulators verapamil and azidopine in wild type and daunorubicin resistant Ehrlich ascites tumour cellsM Sehested, T Skovsgaard, P B Jensen, et al.
Biochemical Pharmacology|August 3, 1993
Antagonistic effect of the cardioprotector (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) on DNA breaks and cytotoxicity induced by the topoisomerase II directed drugs daunorubicin and etoposide (VP-16)M Sehested, P B Jensen, B S Sørensen, et al.
Pageof 3